Literature DB >> 23699676

How does use of a prescription monitoring program change pharmacy practice?

Traci C Green1, Marita R Mann, Sarah E Bowman, Nickolas Zaller, Xaviel Soto, John Gadea, Catherine Cordy, Patrick Kelly, Peter D Friedmann.   

Abstract

OBJECTIVES: To assess differences in prescription monitoring program (PMP) use between two states with different PMP accessibility (Connecticut [CT] and Rhode Island [RI]), to explore use of PMPs in pharmacy practice, and to examine associations between PMP use and pharmacists' responses to suspected diversion or "doctor shopping."
DESIGN: Descriptive nonexperimental study.
SETTING: CT and RI from March through August 2011. PARTICIPANTS: Licensed pharmacists in CT and RI. INTERVENTION: Anonymous surveys e-mailed to pharmacists MAIN OUTCOME MEASURES: PMP use, use of patient reports in pharmacy practice, and responses to suspected doctor shopping or diversion.
RESULTS: Responses from 294 pharmacists were received (CT: 198; RI: 96). PMP users were more likely to use the PMP to detect drug abuse (CT: 79%; RI: 21.9%; P < 0.01) and doctor shopping (67%; 7%; P < 0.01). When faced with suspicious medication use behavior, PMP users were less likely than nonusers to discuss their concerns with the patient (adjusted odds ratio 0.48 [95% CI 0.25-0.92]) but as likely to contact the provider (0.86 [0.21-3.47]), refer the patient back to the prescriber (1.50 [0.79-2.86]), and refuse to fill the prescription (0.63 [0.30-1.30]). PMP users were less likely to state they were out of stock of the drug (0.27 [0.12-0.60]) compared with nonusers. Pharmacists reported high interest in attending continuing education on safe dispensing (72.8%).
CONCLUSION: Pharmacists are important participants in the effort to address prescription drug misuse and abuse. Current PMP use with prevailing systems had limited influence on pharmacy practice. Findings point to future research and needed practice and education innovations to improve patient safety and safer opioid dispensing for pharmacists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23699676     DOI: 10.1331/JAPhA.2013.12094

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  12 in total

1.  Dental opioid prescribing and multiple opioid prescriptions among dental patients: Administrative data from the South Carolina prescription drug monitoring program.

Authors:  Jenna L McCauley; J Madison Hyer; V Ramesh Ramakrishnan; Renata Leite; Cathy L Melvin; Roger B Fillingim; Christie Frick; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2016-04-05       Impact factor: 3.634

2.  Systematic Literature Review of Prescription Drug Monitoring Programs.

Authors:  Aditya Ponnapalli; Adela Grando; Anita Murcko; Pete Wertheim
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

3.  Promising roles for pharmacists in addressing the U.S. opioid crisis.

Authors:  Wilson M Compton; Christopher M Jones; Jack B Stein; Eric M Wargo
Journal:  Res Social Adm Pharm       Date:  2017-12-31

Review 4.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

5.  Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis.

Authors:  Tara Gomes; David Juurlink; Zhan Yao; Ximena Camacho; J Michael Paterson; Samantha Singh; Irfan Dhalla; Beth Sproule; Muhammad Mamdani
Journal:  CMAJ Open       Date:  2014-10-01

6.  Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.

Authors:  Patricia R Freeman; Geoffrey M Curran; Karen L Drummond; Bradley C Martin; Benjamin S Teeter; Katharine Bradley; Nancy Schoenberg; Mark J Edlund
Journal:  Res Social Adm Pharm       Date:  2018-09-14

7.  Prescription drug monitoring program utilization in Kentucky community pharmacies.

Authors:  Sarah E Wixson; Karen Blumenschein; Amie J Goodin; Jeffery Talbert; Patricia R Freeman
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

8.  The opioid overdose epidemic: opportunities for pharmacists.

Authors:  Li-Tzy Wu; Udi E Ghitza; Anne L Burns; Paolo Mannelli
Journal:  Subst Abuse Rehabil       Date:  2017-07-31

9.  Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Authors:  Traci C Green; Emily F Dauria; Jeffrey Bratberg; Corey S Davis; Alexander Y Walley
Journal:  Harm Reduct J       Date:  2015-08-06

Review 10.  Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review.

Authors:  Ashley-Nicole Carmichael; Laura Morgan; Egidio Del Fabbro
Journal:  Subst Abuse Rehabil       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.